Tools & Resources

• Exercise and Psoriasis
• Is Your Psoriasis Under Control?
• Photos: Psoriasis Triggers
• Moderate to Severe Psoriasis
• Life With Psoriasis
• Makeup Tips for Psoriasis

News and FeaturesRelated to Psoriasis

61. Psoriasis Drug Raptiva Gets FDA Warning
    
    (Editor's note: On April 8, 2009, Genentech announced it was voluntarily pulling Raptiva from the market.) Oct. 16, 2008 -- The psoriasis drug Raptiva is getting a "black box" warning, the FDA's sternest warning, about the risk of life-threatening infections including a rare brain infection and meni
    Read Full Article
62. Experimental Psoriasis Drug Takes on Enbrel
    
    Sept. 19, 2008 -- An experimental drug called ustekinumab shows better treatment results than an established drug, Enbrel, for treating moderate to severe plaque psoriasis in a new trial. In a news release, the drug company Centocor, which makes ustekinumab and sponsored the study, calls the new dru
    Read Full Article
63. FDA Panel OKs Enbrel for Psoriasis in Children
    
    June 19, 2008 -- The biologic drug Enbrel has gotten the green light from an FDA advisory committee to treat moderate to severe plaque psoriasis in children and teens who have tried other psoriasis treatments. The FDA's dermatologic and ophthalmic drugs advisory committee spent yesterday weighing En
    Read Full Article
64. FDA Panel Backs New Psoriasis Drug
    
    June 17, 2008 -- Experts told the FDA Tuesday that it should approve an experimental psoriasis drug despite evidence the drug may cause cancer after long-term use. The medication, called ustekinumab, has been shown to reduce the itchy and scaly symptoms of the moderate and severe forms of the skin d
    Read Full Article
65. New Psoriasis Drug Shows Promise
    
    May 15, 2008 -- A new biologic drug called ustekinumab may ease plaque psoriasis, two new studies show. Ustekinumab targets two inflammatory chemicals called interleukins 12 and 23, which are involved in psoriasis. Centocor, the drug company that makes ustekinumab, has already submitted the drug for
    Read Full Article
66. New Psoriasis Drug Passes Hurdle
    
    April 17, 2008 -- A novel immune-suppressing drug appears to effectively treat moderate to severe plaque psoriasis, according to a new report published in The Lancet. Psoriasis is a chronic inflammatory skin condition that affects about 7.5 million Americans, according to the National Institutes of
    Read Full Article
67. Psoriasis: 7 New Genetic Clues
    
    April 3, 2008 -- Scientists have discovered seven genetic variations linked to psoriasis. If confirmed in other studies, those gene variants may make good targets for new psoriasis drugs, note the researchers, who included Anne Bowcock, PhD, genetics professor at Washington University School of Medi
    Read Full Article
68. Enbrel Works for Kids With Psoriasis
    
    Jan. 16, 2008 -- The itchy, red, and silvery skin patches that are the hallmark of psoriasis were constant companions for Maria Anichini from the age of 6. At times they covered almost every inch of her body, causing her to choose long sleeves and pants even in the broiling heat of summer so people
    Read Full Article
69. Severe Psoriasis May Up Risk of Death
    
    Dec. 17, 2007 -- Psoriasis is not generally thought of as life-threatening, but it just might be for those with the severest forms of the disease. People with severe psoriasis had a 50% increased risk of death compared with people without the inflammatory skin disease in a newly reported study. Men
    Read Full Article
70. Smoking May Raise Psoriasis Risk
    
    Oct. 29, 2007 -- Smoking not only takes its toll on your body from the inside, but a new study shows it also affects how your skin looks and feels on the outside. Researchers found that smoking increases the risk of psoriasis, which causes symptoms such as inflammation, redness, itching, and scaling
    Read Full Article